Benefit and Toxicity to PD-1 Blockade Varies by Ethnicity in Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Benefit and Toxicity to PD-1 Blockade Varies by Ethnicity in Patients with Advanced Melanoma: An International Multicenter Observational Study
Br J Dermatol 2022 Mar 16;[EPub Ahead of Print], X Bai, AN Shoushtari, A Betof Warner, L Si, B Tang, C Cui, X Yang, X Wei, HT Quach, CG Cann, MZ Zhang, L Pallan, C Harvey, MS Kim, G Kasumova, T Sharova, JV Cohen, DP Lawrence, C Freedman, RM Fadden, KM Rubin, DT Frederick, KT Flaherty, GV Long, AM Menzies, RJ Sullivan, GM Boland, DB Johnson, J GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.